202330-74-3

Upstream product

• 15852-73-0 (3-Bromophenyl)methanol 
• 107-30-2 chloromethyl methyl ether 

Downstream Products

• 202330-76-5 1,4-bis(3-[(methoxymethoxy)methyl]phenylthio)-2,3,5,6-tetrakis(phenylthio)benzene 
• 202330-73-2 1,4-bis[3-(bromomethyl)phenylthio]-2,3,5,6-tetrakis(phenylthio)benzene 
• 611222-49-2 3-[3-isopropenylstyryl]-2,4,4-trimethyl-1-cyclohexene 
• 611222-51-6 3-(3-isopropylphenethyl)-2,4,4-trimethyl-1-cyclohexene 
• 103040-22-8 3-isopropenylbenzyl chloride 
• 123926-81-8 3-(1-Methylethenyl)benzenemethanol 
• 611222-42-5 2-(3-methoxymethoxymethyl-phenyl)-propan-2-ol 
• 202330-75-4 3-mercaptobenzyl methoxymethyl ether 

Relevant academic research and scientific papers

AZOLE-SUBSTITUTED PYRIDINE COMPOUND

The present invention provides a compound represented by formula [I'| shown below or a pharmaceutically acceptable salt thereof that has an inhibitory effect on 20-HETE producing enzyme, wherein the structure represented by formula [III] shown below represents any of the structures represented by formula group [IV] shown below, wherein R1 represents a hydrogen atom, a fluorine atom, methyl, etc.; R2, R3, and R4 each independently represent a hydrogen atom, a fluorine atom, or methyl; W represents a single bond, C1-3alkanediyl, or the formula -O-CH2CH2-; and ring A represents (a) substituted C4-6cycloalkyl, (b) substituted 4- to 6-membered saturated nitrogen-containing heterocyclyl, (c) substituted phenyl, (d) substituted pyridyl, (e) substituted 2,3-dihydrobenzofuran, (f) 4- to 6-membered saturated oxygen-containing heterocyclyl, etc.

AROMATIC RING COMPOUND

Provided is an aromatic ring compound having a GPR40 agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has a GPR40 agonist activity, and is useful as an agent for the prophylaxis or treatment of diabetes and the like.

Total synthesis of (±)-abieta-8, 11, 13-trien-7ss-ol

The first total synthesis of (±)-abieta-8,11,13-trien-7ss-ol (1) was accomplished, in which α-cyclocitral was used as the A ring synthon, and triphenylphosphonium chloride (9), which was obtained from mbromobenzyl alcohol (4) via five steps, as the C ring

Potassium Cryptate of a Macrobicyclic Ligand Featuring a Reducible Hexakis(phenylthio)benzene Electron-Acceptor Site

The synthesis and structural characterization of the macrobicyclic ligand 1 containing a reducible hexakis(phenylthio)benzene electron-acceptor site is described. It is based on the condensation of the tetraoxa-di-azamacrocycle 3 with a suitably functiona